Association of functional variants of PTPN22 and tp53 in psoriatic arthritis: A case-control study

Arthritis Research and Therapy

Volumn 8, Issue 1, 2006, Pages

  Butt, Christopher ^a,b   Peddle, Lynette ^a   Greenwood, Celia ^c   Hamilton, Sean ^a,b   Gladman, Dafna ^d   Rahman, Proton ^a,b  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PROTEIN P53; PROTEIN TYROSINE PHOSPHATASE; PTPN22 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN; TRYPTOPHAN;

ADULT; CANADA; CASE CONTROL STUDY; CAUCASIAN; COHORT ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; GENOTYPE; HUMAN; MALE; PSORIATIC ARTHRITIS; RISK;

ADULT; ARGININE; ARTHRITIS, PSORIATIC; CASE-CONTROL STUDIES; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; NEWFOUNDLAND AND LABRADOR; ONTARIO; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; PROTEIN TYROSINE PHOSPHATASES; RISK; TRYPTOPHAN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 42049096857     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar1880     Document Type: Article

References (14)

1. Hasegawa K, Martin F, Huang G, Tumas D, Diehl L, Chan AC: PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 2004, 303:685-689.
2. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, MacMurray J, Meloni GF, Lucarelli P, Pellecchia M, et al.: A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004, 36:337-338.
3. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, Ardlie KG, Huang Q, Smith AM, Spoerke JM, et al.: A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis Am J Hum Genet 2004, 75:330-337.
4. Kyogoku C, Langefeld CD, Ortmann WA, Lee A, Selby S, Carlton VE, Chang M, Ramos P, Baechler EC, Batliwalla FM, et al.: Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004, 75:504-507.
5. Nistor I, Nair RP, Stuart P, Hiremagalore R, Thompson RA, Jenisch S, Weichenthal M, Abecasis GR, Qin ZS, Christophers E, et al.: Protein tyrosine phosphatase gene PTPN22 polymorphism in psoriasis: Lack of evidence for association. J Invest Dermatol 2005, 125 395-396.
6. Criswell LA, Pfeiffer KA, Lum RF, Gonzales B, Novitzke J, Kern M, Moser KL, Begovich AB, Carlton VE, Li W, et al.: Analysis of families in the Multiple Autoimmune Disease Genetics Consortium (MADGC) collection: The PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 2005, 76:561-571.
7. Olsen NJ, Moore JH, Aune TM: Gene expression signatures for autoimmune disease in peripheral blood mononuclear cells. Arthritis Res Ther 2004, 6:120-128.
8. Maas K, Westfall M, Pietenpol J, Olsen NJ, Aune T: Reduced p53 in peripheral blood mononuclear cells from patients with rheumatoid arthritis is associated with loss of radiation-induced apoptosis. Arthritis Rheum 2005, 52:1047-1057.
9. Taubert H, Thamm B, Meye A, Bartel F, Rost AK, Heidenreich D, John V, Brandt J, Bache M, Wurl P, et al.: The p53 status in juvenile chronic arthritis and rheumatoid arthritis. Clin Exp Immunol 2000, 122:264-269.
10. Lee YH, Kim YR, Ji JD, Sohn J, Song GG: p53 codon 72 polymorphism and rheumatoid arthritis. J Rheumatol 2001, 28:2392-2394.
11. Rahman P, Elder JT: Genetic epidemiology of psoriasis and psoriatic arthritis. Ann Rheum Dis 2005:iI37-ii39.
12. Firestein GS, Nguyen K, Aupperle KR, Yeo M, Boyle D, Zvaifler NJ: Apoptosis in rheumatoid arthritis: P53 overexpression in rheumatoid arthritis synovium. Am J Pathol 1996, 149:2143-2151.
13. Hannuksela-Svahn A, Paakko P, Autio P, Reunala T, Karvonen J, Vahakangas K: Expression of p53 protein before and after PUVA treatment in psoriasis. Acta Derm Venereol 1999, 79:195-199.
14. Salvador G, Sanmarti R, Garcia-Peiro A, Rodriguez-Cros JR, Munoz-Gomez J, Canete JD: p53 expression in rheumatoid and psoriatic arthritis synovial tissue and association with joint damage. Ann Rheum Dis 2005, 64:183-187.